|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07K 16/28 | |
| A61K 39/00 |
| (11) | Patento numeris | 2914627 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13786884.0 |
| Europos patento paraiškos padavimo data | 2013-10-30 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-09-09 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-04-07 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2013/067583 |
| Data | 2013-10-30 |
| (87) | Numeris | WO 2014/070934 |
| Data | 2014-05-08 |
| (30) | Numeris | Data | Šalis |
| 201261720289 P | 2012-10-30 | US |
| (72) |
ZHANG, Yongke, US
YU, Guo-Liang, US
ZHU, Weimin, US
|
| (73) |
Apexigen, Inc.,
75 Shoreway Road, Suite C, San Carlos, CA 94070,
US
|
| (54) | ANTI-CD40 ANTIBODIES AND METHODS OF USE |
| ANTI-CD40 ANTIBODIES AND METHODS OF USE |